Brunojoy 300 Tablet ER
Marketer
Mitis Biomedics Ltd
Salt Composition
Bupropion (300mg)
Overview Brunojoy 300 Tablet ER
Deprenix 300mg Extended-Release tablets treat depression and nicotine dependence. This medication works by boosting levels of neurotransmitters in the brain, promoting relaxation and a calming effect. Deprenix 300mg ER can be taken with or without food, but consistently at the same time each day. Complete the prescribed course, even if symptoms improve; abruptly stopping treatment may worsen your condition. Potential side effects include sleep disturbances, allergic reactions, concentration difficulties, perspiration, headaches, nausea, vomiting, dry mouth, dizziness, and drowsiness. Avoid activities requiring alertness, such as driving, while taking this medicine. Most side effects are transient. However, persistent or bothersome side effects warrant medical attention. Before starting treatment, disclose any history of seizures or alcohol consumption. Report any unusual mood shifts or suicidal ideation to your physician immediately.
Primary Ingredients of Brunojoy 300 Tablet ER
No text provided to rephrase.
Uses of Brunojoy 300 Tablet ER
Tobacco dependence and depressive disorder
Major Benefits of Brunojoy 300 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Brunojoy 300 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Brunojoy 300 Tablet ER:
- Insomnia (difficulty in sleeping)
- Allergic reaction
- Impaired concentration
- Sweating
- Headache
- Nausea
- Vomiting
- Dizziness
- Dryness in mouth
- Taste change
- Abdominal pain
- Agitation
- Anxiety
- Fever
- Constipation
- Tremors
How to use Brunojoy 300 Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Brunojoy 300 ER tablets can be consumed with or without food, although consistent timing is recommended.
How Brunojoy 300 Tablet ER works:
Extended-release Brunojoy 300mg tablets address depressive symptoms by elevating neurotransmitter concentrations, thereby improving mood regulation. The precise mechanism by which it aids in smoking cessation remains unclear.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Brunojoy 300 Extended-Release tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Extended-release Brunojoy 300mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCAUTION
Extended-release Brunojoy 300 mg tablets require careful consideration during lactation. Mothers should discontinue breastfeeding throughout treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Extended-release Brunojoy 300mg tablets can induce side effects that impair driving capabilities. These effects may include dizziness or lightheadedness, potentially compromising concentration and judgment, thus impacting safe driving.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Brunojoy 300 Extended-Release tablets. Dosage modification of Brunojoy 300 ER may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Brunojoy 300 ER tablets cautiously, potentially requiring dosage modification. Medical supervision is recommended, with close monitoring for adverse reactions.
What if you forget to take Brunojoy 300 Tablet ER :
Omit any missed Brunojoy 300 Tablet ER dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Brunojoy 300 Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Propiophenone Derivative |
| Developing Habits | No. |
| Type of Therapy | Neuroscience of the Central Nervous System |
| Behavior Class | Norepinephrine and dopamine reuptake inhibitor |


